Sign in
4

Changes in Ownership

Yarrow Bioscience, Inc. Filed Acc 0001209191-20-018228

Chief Scientific Officer acquired 61,392 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Stuart Iain · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2020-03-09 Grant or award : show line 1 in the form +7,306 7,306 D
2020-03-09 Grant or award : show line 2 in the form +54,086 61,392 D

Table II: Derivative

5 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-03-09 Grant or award : show line 3 in the form Stock Options +23,696 $14.43 2026-11-15 23,696 23,696 D
2020-03-09 Grant or award : show line 4 in the form Stock Options +7,701 $9.10 2027-08-08 7,701 7,701 D
2020-03-09 Grant or award : show line 5 in the form Stock Options +17,772 $10.73 2028-02-27 17,772 17,772 D
2020-03-09 Grant or award : show line 6 in the form Stock Options +45,020 $6.37 2029-01-01 45,020 45,020 D
2020-03-09 Grant or award : show line 7 in the form Stock Options +57,086 $6.81 2030-02-24 57,086 57,086 D
Loading xslF345X03/doc4.xml…